SCHEMBL1343774

SCHEMBL1343774

Cc1ccc(NC(=O)Nc2ncc(C(=O)Nc3nncs3)s2)c(C(=O)C2CCCC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 6/20 0.42
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
MAPK14 Q16539 3/20 0.38
MAPK13 O15264 1/20 0.38
EGFR P00533 1/20 0.38
FYN P06241 1/20 0.38
HCK P08631 1/20 0.38
SRC P12931 1/20 0.38
JAK3 P52333 1/20 0.38
MAPK12 P53778 1/20 0.38
MAPK11 Q15759 1/20 0.38
TAAR1 Q96RJ0 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1342258 0.86 LCK (0.45) LCKSMN1; SMN2KMT2AGAAMAPT
SCHEMBL6693554 0.85 SMN1; SMN2 (0.37) SMN1; SMN2NPC1RAB9AKMT2AKDM4E
SCHEMBL1342828 0.84 SMN1; SMN2 (0.43) LCKSMN1; SMN2RAB9AKMT2AALDH1A1
SCHEMBL1341394 0.84 SMN1; SMN2 (0.42) LCKSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL1342927 0.83 LCK (0.42) LCKSMN1; SMN2KMT2AGAAMAPT
SCHEMBL1343084 0.83 LCK (0.42) LCKSMN1; SMN2KMT2AGAAMAPK14
SCHEMBL1343709 0.82 LCK (0.42) LCKSMN1; SMN2KMT2AGAAMAPT
SCHEMBL1342476 0.81 LCK (0.41) LCKSMN1; SMN2MAPK14MAPK13EGFR
SCHEMBL1342702 0.81 MAPK14 (0.40) SMN1; SMN2NPC1RAB9AMAPK14MAPK13
SCHEMBL1342321 0.80 LCK (0.42) LCKSMN1; SMN2MAPTMAPK14MAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063081-B2 N-(2-Phenoxyphenyl)-N'-(thiazol-2-yl)urea; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase NOVO NORDISK A/S (DK) 2011-11-22 US disclosed
US-7897628-B2 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase NOVO NORDISK A/S (DK) 2011-03-01 US disclosed